EEG Correlates of Dream Recall in Depressed Outpatients and Healthy Controls

The present study explored EEG correlates of dream recall in 17 symptomatic, unmedicated depressed patients and in 19 healthy adults. EEG segments from the last 30 minutes of sleep, from the five minutes following morning awakening, and the absolute difference between sleep and waking EEG were contrasted between the two groups of participants during successful dream recall and during no recall. Period amplitude analysis was used to quantify EEG frequencies. Increased high-frequency beta incidence in the right hemisphere and amplitude in both hemispheres during sleep were associated with dream recall in both patient and control groups. Depressed patients also showed higher delta amplitude in both hemispheres during sleep associated with recall, but this effect did not reach significance. With regard to the changes between sleep and wakefiilness, a smaller change in right hemisphere beta and delta incidence characterized successful recall in healthy controls. By contrast, those with depression showed recall success when the sleep/wake shifts in right hemisphere beta and delta incidence were larger. Recall failure was characterized by small EEG shifts from sleep to wakefulness in the depressed group. The same effects were observed for beta and delta amplitude measures, except that healthy controls showed a large shift in delta amplitude in the sleep-wake transition during successful recall but not during recall failure. Recall in those with depression was associated with a dramatic shift in left hemisphere delta amplitude. These findings provide support for Koukkou and Lehmann's (1983, 1993) state-shift hypothesis of dream recall in healthy controls (except for left hemisphere delta amplitude) but not in the depressed. It appears that in order to recall a dream, depressed patients must undergo larger shifts in brain activity and perhaps a different pattern of reorganization of EEG frequencies than controls. This finding may account for the low rates of recall reported previously in this clinical group.